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1) Department of Parasitology and 2) Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The NetherlandsAbstractFollowing the success of nucleic acid-based detection in virology and bacteriology, multiplex real-time PCRs are increasingly used as ﬁrst-line
diagnostics in clinical parasitology, replacing microscopy. The detection and quantiﬁcation of parasite-speciﬁc DNA in faeces is highly sensitive
and speciﬁc and allows for cost-effective high-throughput screening. In this paper we discuss the clinical consequences of this radical change in
diagnostic approach, as well as its potential drawbacks. In the Netherlands, routine diagnostic laboratories have been pioneering the
implementation of multiplex real-time PCR for the detection of pathogenic intestinal protozoa and this has resulted in increased
detection rates of Giardia lamblia and Cryptosporidium spp. As a consequence of this new diagnostic approach, expertise in the ﬁeld of
parasite morphology by conventional light microscopy seems to be disappearing in most of the high-throughput microbiological
laboratories. As a result, to maintain a high standard of care, a formalized exchange of critical information between clinicians and
laboratory staff is necessary to determine the most appropriate testing either in local laboratories or in reference centres, based on
clinical signs and symptoms, exposure and immune status. If such a diagnostic algorithm is lacking, important infections in travellers,
immigrants and immunocompromised patients may be missed.
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E-mail: lvanlieshout@lumc.nlIntroductionEver since the introduction of light microscopy, morphological
determination of intestinal protozoa and helminths has been the
cornerstone of routine laboratory diagnosis in parasitology.
Some examples are given in Fig 1. This diagnostic approach
seems to be in sharp contrast to other microbiological ﬁelds,
such as virology and bacteriology, where innovative modern
technology has replaced the more classical diagnostic methods
(i.e. viral culture and biochemical identiﬁcation of bacteria) in
the last two decades [1]. This lag in diagnostic innovation can be
partly explained by the fact that detection and differentiation of
cysts, ova and larvae, when performed by well-trainedMicrobiol Infect 2015; 21: 520–528
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.03.015technicians, are simple, fast and inexpensive [2]. In addition,
microscopy also allows for detection of unexpected parasites,
which may be particularly appropriate, as well as convenient,
when the clinical presentation is atypical or vague.
In resource-limited health systems the advantages of mi-
croscopy are more obvious. When labour costs are low and
investment in new technologies is limited, molecular techniques
have little to offer for daily clinical practice. Moreover, basic
microscopy procedures are sufﬁcient to detect the most
prominent parasite species in regions with a high prevalence
and intensity of intestinal parasites. The incentives for investing
in the development and implementation of new routine para-
sitological tests have therefore been low in these settings.
However, shifting parasite distribution and successful control
programmes increase the need for more sensitive and high-
throughput diagnostic procedures to identify the remaining
infectious reservoir [3–5].
In addition, in many western countries, conventional mi-
croscopy continues to be the ﬁrst-line diagnostic procedure in
most clinical parasitological laboratories [6]. The advantage ofious Diseases. Published by Elsevier Ltd. All rights reserved
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FIG. 1. Examples of parasitic infections which, once detected by a trained technician via microscopic examination of stool samples, can be relatively
easily differentiated. (a) Egg of Schistosoma mansoni, (b) L1-stage larvae of Strongyloides stercoralis, (c) Giardia lamblia cysts in a iodine-stained smear, (d)
Cryptosporidium sp. oocysts in a modiﬁed Ziehl Neelsen stain smear.
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the limitations, i.e. low sensitivity and the necessity for speciﬁc
staining and concentration procedures to detect certain para-
site species. However, increasing costs of labour, including the
need for continuous training, in combination with the low yield
of parasite-positive cases, and hence the requirement for mul-
tiple sample examination has made microscopy expensive in the
western setting. There is a growing willingness of well-equipped
laboratories to radically adapt their diagnostic algorithm and
introduce high-throughput DNA-detecting assays.
The actual process of introducing DNA-detecting assays as
ﬁrst-line routine diagnostic procedures is not only dependent
on patient populations and parasite prevalence, but also
strongly dependent on sample logistics and the national reim-
bursement systems. For example, the mixing of samples with
preservatives like formalin has a negative effect on the PCR
output [7], and so the implementation of DNA-detecting assays
requires a logistical system that allows for fresh sample analysis.
In addition, the ﬁnancial compensation for molecular testing
should match actual investments and running costs made by the
laboratory.
In the Netherlands there is an irreversible trend towards the
application of new diagnostic tools for intestinal parasites.
Several leading Dutch parasitologists have a track record overClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologymore than a decade in the ﬁeld of PCR-based diagnosis of human
parasitic diseases. They have published numerous studies on the
implementation and validation of multiplex real-time PCR as a
routine diagnostic tool and the comparison between DNA
detection procedures and microscopy [7–10]. This, in combi-
nation with logistical issues such as sample collection and
reimbursement systems, probably explains why the Netherlands
is internationally at the forefront of routine diagnosis of
diarrhoea-causing protozoa by the use of real-time PCR.
Currently approximately 32 of the 72 registered Dutch hospital
microbiology laboratories (http://www.nvmm.nl/laboratoria)
participate in the Dutch national quality control scheme for the
detection of gastrointestinal protozoa in faecal specimens by
molecular methods, organized by the Parasitology section of the
SKML, the Dutch Foundation for Quality Assessment in Medical
Laboratories (see http://www.skml.nl/en/home/sections/
parasitology). A substantial proportion of these laboratories
have abandoned microscopy as a ﬁrst-line diagnostic procedure
and it is likely that more Dutch laboratories will follow.
The increasing interest in the clinical application of PCR-
based diagnosis in parasitology is reﬂected in the large num-
ber of excellent reviews that have been published in the last few
years [7–15]. For a long time molecular diagnosis was
restricted to specialized national reference centres, for exampleand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 520–528
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species [12]. However, several studies showed that parasite
DNA detection in stool samples is a highly sensitive and speciﬁc
tool, which also suits the routine clinical setting [10]. The higher
detection rates found with PCR-based methods are consistent
and cannot be explained by low assay speciﬁcity, contamination,
or ongoing excretion of dead DNA. Nonetheless, PCR results
should always be assessed in the context of clinical patient
characteristics [10]. A close collaboration between clinician and
laboratory is therefore critical.
This paper provides an overview of the most important
possible clinical consequences of replacing conventional stool
microscopy by DNA-detecting assays, particularly in travellers,
immigrants and immunocompromised patients. This paper fo-
cuses exclusively on industrialized countries, in particular
within Western Europe, where multiplex real-time PCR diag-
nosis is rapidly replacing conventional microscopy.Low-risk patientsThe diagnostic performance of multiplex real-time PCR for the
detection of pathogenic intestinal protozoa in non-travellers
living in an industrialized country has been extensively studied
and reviewed by several authors [7–15]. The most commonly
used multiplex PCR targets are Giardia lamblia, Cryptosporidium
spp. and Entamoeba histolytica, which are globally the most
important diarrhoea causing intestinal protozoa. Studies
comparing this protozoa multiplex PCR in a routine setting
with microscopy or copro-antigen detection all conclude that
faecal DNA detection is more speciﬁc, more sensitive and less
labour intensive [16–18]. In addition, G. lamblia DNA becomes
undetectable within 1 week after metronidazole treatment,
conﬁrming rapid clearance of DNA in faecal samples following
successful therapy [19].
Some studies also included PCR testing of Dientamoeba fra-
gilis, although the pathogenicity of this protozoa is highly
controversial [20,21]. Also the importance of Blastocystis sp. as a
pathogen is still poorly understood [22]. Including these pro-
tozoa in primary routine diagnostic procedures is therefore the
subject of debate as DNA detection surveys show exceptionally
high levels of positive cases without clear-cut associations with
clinical symptoms [23]. For Blastocystis multiple subtypes have
been identiﬁed by nucleic acid sequencing and unlike D. fragilis,
certain subtypes seem to be associated with clinical symptoms
[22]. Further studies may elucidate the potential clinical rele-
vance of both protozoa.
Despite the fact that infections with E. histolytica are extremely
rare in Europe and are always directly or indirectly related to
travel to high-risk countries, most laboratories routinely includeClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectthis target in their multiplex PCR for diarrhoea-causing pro-
tozoa. Accurate diagnosis of E. histolytica infection is essential to
prevent invasive disease, as well as to avoid transmission to
others [24]. Because cysts are morphologically indistinguishable
from the non-pathogenic Entamoeba dispar, microscopy has very
little to offer and PCR surpasses all other diagnostic alternatives.
Occasionally, a patient may present with an acute amoebic liver
abscess despite a negative stool PCR. Therefore antibody
detection also remains an important diagnostic tool for amoe-
biasis and serology should always be performed in at-risk patients
with upper abdominal pain and fever [24].
So, in conclusion, at least in the Netherlands, real-time PCR
is increasingly used as the primary diagnostic tool to examine
stool samples for parasitic infections in low-risk patients. The
number of parasitic infections potentially missed when per-
forming PCR only, is very limited and could be mitigated by
using an appropriate algorithm [17]. For example, additional
diagnostic attention should be paid to patients who have
noticed worms or proglottids after defecation or patients
suffering from perianal pruritus. Other potential risk groups are
discussed below.Travellers and immigrantsSchistosomiasis
Second only to malaria, schistosomiasis is the most frequently
diagnosed parasitic disease in the febrile returning traveller and
is often related to bathing in lakes and rivers in sub-Saharan
Africa [25,26], although transmission in Corsica has also
recently been described [27]. Travellers often present with
acute Katayama fever [28], whereas chronically infected immi-
grants present with abdominal signs and symptoms [29].
Adequate diagnosis and treatment of schistosomiasis is key to
preventing late genitourinary, gastrointestinal or neurological
morbidity [30–33].
Diagnosis of Katayama fever may be challenging, because
these symptoms occur early, roughly 2 to 6 weeks after
exposure [28,29,34,35]. Microscopic detection of Schistosoma
eggs in urine (Schistosoma haematobium) or faeces (Schistosoma
mansoni) is the reference standard, but also notoriously insen-
sitive in the low-intensity infections typical of travellers and can
only be detected starting 6 weeks after water contact [29].
Several schistosome serological tests have been developed,
many of which are in-house assays based on egg or worm
extracts. Seroconversion generally takes 4–8 weeks, but may
sporadically be later [36–38]. Although the sensitivity of
serological tests ranges from 41% to 78% [39], it is still the
most suitable diagnostic test currently available, particularly for
travellers. Because positive results persist for many years, noious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 520–528
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[40].
Assays to detect Schistosoma DNA in faeces or urine have
been developed in numerous laboratories as a more sensitive
alternative to egg microscopy [7,41,42]. The results are
promising, although most research has been done with chronic
infections in endemic areas [43,44]. Schistosoma mansoni DNA
in serum has been reported as a more sensitive diagnostic tool
than serology in the diagnosis of acute schistosomiasis [45].
Unfortunately, these studies also report persisting positive re-
sults after treatment, probably because of the continued release
of cell-free DNA from degrading schistosomes [41].
Recent developments in detection of schistosome circulating
worm antigen (the circulating anodic CAA and cathodic CCA
antigens) are promising and have resulted in the application of a
point-of-care urine-based test adjusted to resource-poor set-
tings [46,47]. In contrast to DNA detecting assays, which are
generally species restricted, CAA and CCA are genus speciﬁc.
As a result, CAA and CCA can also be detected in urine of
patients with Schistosoma japonicum and Schistosomamekongi
[48], species that occasionally occur in travellers and immi-
grants [49]. Increasingly sensitive laboratory-based CAA
detection systems both for serum and urine seem to also detect
extremely light infections [46,50]. These tests are currently
being evaluated for their application in travellers.
Strongyloides
Compared with schistosomiasis, strongyloidiasis is less
frequently seen in the returning traveller, but more common in
migrants and expatriates as a subclinical disease [51–53].
Eosinophilia can be intermittent and has only been reported in
57–63% of strongyloidiasis patients [54]. Due to autoinfection,
life-threatening disseminated hyperinfections may develop in
chronically infected patients who are treated with immuno-
suppressants, particularly corticosteroids. In addition, other
immunosuppressed conditions such as chronic alcoholism,
chemotherapy, solid organ or haematological transplants pre-
dispose to hyperinfection, whereas human immunodeﬁciency
virus (HIV) is not a risk factor [51,55,56]. Accurate diagnosis is
of paramount importance as treatment of disseminated infec-
tion is extremely difﬁcult [52,57].
Microscopy detection of larvae in the patient’s stool is still
considered the traditional reference standard for Strongyloides
infection. However, even when multiple stool samples are
examined and dedicated concentration procedures (i.e. Baer-
mann and copro-culture) on freshly produced faecal samples
are used, microscopy lacks sensitivity because the number of
excreted larvae can be low.
Serological assays are currently the ﬁrst-choice diagnostic
test for screening of patients at risk of strongyloidiasis,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologypreferably before immunosuppression is initiated. Several in-
house and commercial antibody detecting tests have been
described with a wide range of sensitivity and speciﬁcity. Most
of these tests have a high negative predictive value and are
therefore extremely useful for excluding chronic infections in
immigrants. However, many tests show a low speciﬁcity and
cross-react with other helminths, or they lack sensitivity and
miss the non-chronic infections, which have not yet completed
several cycles of autoinfection [51]. Because antibody levels
usually take months to decrease below detection levels,
serology is less suited for follow up [54].
Real-time PCR for the detection of Strongyloides DNA in
stool samples has been implemented as a routine diagnostic test
in several European reference centres [7], and is particularly
useful for conﬁrming (low-grade) infection in patients with
positive serology or for diagnosing the infection in travellers in
cases where dedicated microscopy procedures cannot be
performed [58]. In addition, PCR may also be applied to sputum
or bronchoalveolar lavage ﬂuids, and may be used for follow up
of patients with disseminated strongyloidiasis [57]. Although
more sensitive than routine microscopy in most settings, low-
intensity infections can still be missed by PCR. Therefore mo-
lecular diagnosis should be repeated several times to fully
exclude infection.
Other travel-related helminths
Geo-helminths. Intestinal helminth infections other than schis-
tosomiasis and strongyloidiasis are increasingly rare in routine
diagnostic laboratories in Western Europe. For example, the
soil-transmitted roundworms Ascaris lumbricoides, Trichuris tri-
chiura and the hookworm species Ancylostoma duodenale and
Necator americanus, which are endemic in some tropical areas,
are not often found in Europe [5,58]. The clinical signs of these
infections are relatively mild and not very speciﬁc, which may
confuse a clinician in the diagnostic process. General abdominal
discomfort, often in combination with eosinophilia, and a suit-
able history of potential exposure, may provide the diagnostic
clue. The standard laboratory test to diagnose these helminths
is microscopy of the characteristic parasite eggs. However, at
least three stool samples should be carefully examined to
exclude infection. Serology is not available. Several PCRs have
been described that reach a high sensitivity and speciﬁcity, but
none have been introduced into routine clinical practice [7].
Tapeworms. Cestodes such as Taenia spp. and Hymenolepis spp.
have a worldwide distribution, but the risk of infection is sub-
stantially higher in communities where humans and the cestode
intermediate host such as cattle and pigs live closely together,
or where food or water is contaminated with embryonated
eggs. Within Western Europe, cestode infections areand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 520–528
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Diphyllobothrium, which beneﬁts from the increasing popularity
of raw ﬁsh dishes [59]. The clinical presentation of intestinal
cestode infections is generally mild and aspeciﬁc. Proglottids, if
present, are often noticed by patients themselves. Preferably
these proglottids are examined by a parasitology reference
centre for further determination with parallel molecular anal-
ysis of a stool sample. With the exception of the potentially
tissue-dwelling species Taenia solium, serology is not useful for
the diagnosis of intestinal cestodes [60].
Food-borne trematodes. Food-borne trematodes are associated
with a wide variety of signs and symptoms [61]. The clinical
presentation depends on the ﬂuke species and may be grouped
as liver, lung or intestinal ﬂukes. The most commonly occurring
ﬂukes are Clonorchis sinensis, Opisthorchis spp., Fasciola spp. and
Paragonimus spp. Globally the number of cases is increasing, but
transmission is highly focal and governed by regional socio-
ecological contexts. Imported cases are relatively rare. In
Western Europe Fasciola hepatica is the only endemic food-
borne trematode, with the exception of a small focus of Opis-
torchis transmission in Italy [62]. Morbidity from food-borne
trematodes depends not only on the species, but also on the
host’s susceptibility, duration of infection and the number of
worms. The most serious clinical consequences are cancer of
the bile duct (in clonorchiasis and opisthorchiasis) and ectopic
infections. Treatment is available and essential; therefore in-
fections should be properly diagnosed.
Direct microscopic detection of eggs in faeces and sputum is
the conventional diagnostic tool, but may be challenging
because of the low numbers and heterogeneous distribution of
eggs in clinical samples. Serological tests are performed by
reference laboratories, but they suffer from cross-reactivity
with other helminths, necessitating complementary micro-
scopy. Several PCRs have been described, but they are not
applied in routine clinical diagnostics [7]. Therefore, the diag-
nostic procedure of a patient with suspected food-borne
trematodes should be carefully discussed with a local parasi-
tological laboratory.
Travel-related protozoa
As for helminth infections, intestinal protozoa occur more
frequently in travellers or immigrants from outside Europe
[58]. The most common pathogenic intestinal protozoa are
Giardia, Cryptosporidium and E. histolytica and only a limited
number of patients are diagnosed with other travel-related
diarrhoea-causing protozoa [58]. This explains why molecular
diagnosis of intestinal protozoa is largely covered by using a
multiplex real-time PCR for the detection of these three in-
testinal protozoa. However, protozoa such as CyclosporaClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcayetanensis and Cystoisospora belli will be missed if the labora-
tory diagnosis is limited to the DNA detection of these three
targets only.
Cyclosporiasis is characterized by long-lasting watery diar-
rhoea and substantial weight loss, and should particularly be
suspected if these symptoms appear after travelling to Central
or Latin America or the Asian countries Nepal and Indonesia.
However, exposure within these endemic countries is not an
absolute requirement. Several food-borne outbreaks have been
reported, so far mainly in the USA, caused by consumption of
imported raw food products such as salads, basil or berries
[63]. Cyclospora oocysts can be seen with simple phase-contrast
or bright-ﬁeld microscopy, or may be visualized using a modi-
ﬁed acid-fast stain, but they are easier to identify using an epi-
ﬂuorescence microscope because they autoﬂuoresce white-
blue. Several stool samples should be examined as intermit-
tent and low-grade shedding of oocysts occurs in the majority
of patients [63,64]. Because most laboratories do not perform
any of these procedures routinely, Cyclospora diagnostics should
always be speciﬁcally requested. PCR is a much more sensitive
diagnostic tool, but is generally conﬁned to centres of expertise
[7]. Commercial multiplex PCRs including for Cyclospora have
become increasingly available. There are no serological assays
to determine human exposure to Cyclospora [63,64].
Cystoisospora infections are very rare in Western Europe,
most infections seen are in HIV-positive immigrants from sub-
Saharan Africa. As for Cyclospora, microscopy is still the most
appropriate diagnostic tool for this microorganism, but lacks
sensitivity. Some centres of expertise may offer real-time PCR
detection of Cystoisospora in clinical samples as a routine diag-
nostic test [65].Immunocompromised patientsImmunocompromised patients may present with more severe
parasitic infections and have an increased risk of reactivation or
exacerbation of chronically carried parasites [66]. As discussed
above, corticosteroids bear the risk of disseminated Strong-
yloides infection, particularly in transplant patients. In addition,
prevalence rates of Cryptosporidium in both transplant and HIV
patients are high and associated morbidity is signiﬁcant, with a
risk of extra-intestinal seeding such as gallbladder and biliary
tract infections. As described above Cryptosporidium molecular
detection has been implemented in many laboratories, largely
reducing the need to perform time-consuming modiﬁed acid-
fast staining procedures (Fig. 1). However, in a setting where
clinical suspicion is high and PCR is repeatedly negative, mi-
croscopy should be performed as most PCRs detect Crypto-
sporidium parvum/Cryptosporidium hominis only and not theious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 520–528
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promised patients [67]. Although treatment options are limited
for cryptosporidiosis, proper diagnosis gives the clinician the
option to consider a change in clinical management to improve
the immune status of the patient.
Although risks of infection are substantially lower, immu-
nocompromised patients may also suffer from severe and
prolonged diarrhoea with dehydration and wasting due to the
other coccidians Cyclospora cayetanensis and Cystoisospora belli,
in particular after travelling to high-risk areas [64]. Molecular
detection allows for rapid and accurate identiﬁcation of these
parasites, but most laboratories have not implemented such a
test in their routine procedures [68]. Consequently, infections
will be easily missed if clinical signs, immune status and travel
history are not properly communicated to the laboratory.
Microsporidia
A variety of clinical syndromes, including gastrointestinal,
neurological, urogenital or eye infections may be caused by
microsporidia, of which Enterocytozoon bieneusi and Encepha-
litozoon intestinalis are the most common species in human
infection [69]. Although microsporidia are traditionally asso-
ciated with HIV infection, they are regularly diagnosed in
transplant recipients suffering from diarrhoea. Infections have
also been documented in immunocompetent children, the
elderly and travellers [70]. Diagnosis by detection of spores
in stool can be done by traditional light microscopy or by
Uvitex ﬂuorescence staining, but is notoriously difﬁcult. Mi-
croscopy for microsporidia has therefore been replaced by
molecular detection methods in many laboratories, but is
mostly only offered on speciﬁc request [7]. As for Crypto-
sporidium, treatment options are limited, in particular for
Enterocytozoon bieneusi. So if possible, management of these
infections should involve a reduction in immunosuppression
or the use of antiretrovirals in the case of HIV-infected in-
dividuals. With an increasing number of immunocompro-
mised travellers, physicians should be trained in recognizing
high-risk travellers and referring them to specialized travel
clinics.Future trendsThe availability of highly sensitive and speciﬁc molecular
detection techniques enables high-throughput and cost-
effective screening of faecal samples without the need for mi-
croscopy. The implementation of such an approach may be of
particular interest in a setting of low parasite prevalence. For
example, multiplex real-time PCR assays were used in a
recently published prospective study where more than 500Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyasymptomatic long-term travellers to the (sub)tropics were
screened 2 weeks and 12 weeks after their return, to exclude
infection with E. histolytica, G. lamblia, Cryptosporidium spp. and
Strongyloides stercoralis [71]. From a laboratory point of view
multiplex real-time PCR could be easily and efﬁciently com-
bined with the detection of other, non-parasitic, microorgan-
isms. This will lead to the further development of semi-
automated and fully automated high-throughput platforms for
the simultaneous detection of viral, bacterial and parasitic
enteropathogens [10,72]. However, to assure the reliable
performance of molecular assays in primary routine diagnostic
care, it is essential that a solid system of quality assurance and
control is put in place and integrated in all procedures [73].
New diagnostic techniques, being either omic-technology or
advanced DNA detection-based approaches such as next-
generation sequencing, are increasingly explored for their use
in clinical microbiology [74]. For the detection of intestinal
parasites these expensive and high-tech tools are, so far, not
likely to conquer routine diagnostics as they have done in
bacteriology. Nevertheless, some of these technologies, such as
mass spectrometry, may lead to the discovery of novel bio-
markers that can be incorporated in affordable point-of-care
diagnostic tests [15].Concluding remarksDespite the overwhelming success of molecular detection
techniques, microscopy remains the cornerstone for the diag-
nosis of many parasites. Particularly for the detection of rare or
emerging parasitic infections, such as food-borne trematodes,
for which often no species-speciﬁc molecular or serology tests
are available, parasitology still relies on classical tools to di-
agnose patients. However, as microscopy remains labour
intensive and highly observer-dependent, molecular detection
techniques, such as real-time PCR, are excellent alternatives, in
particular in settings where the number and range of parasitic
infections is low and personnel costs are substantial. Conse-
quently, multiplex DNA detecting tests will be increasingly used
in routine microbiology laboratories as an affordable one-for-all
high-throughput approach to screen for the most common
intestinal parasites, without performing microscopy. However
suitable for the majority of patients without any risk factor with
regards to exposure or immune status; this trend bears the risk
of microbiology laboratories merely reporting PCR results of
the most common parasites rather than offering clinical con-
sultancy. In addition, skilled clinical parasitologists who are
familiar with the laboratory diagnosis of relatively rare parasitic
diseases will be lost. Therefore, clinicians should be aware that
relevant information on exposure, immune status and clinicaland Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 520–528
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laboratory to guide solid differential diagnosis and to determine
the most appropriate diagnostic procedures (Fig. 2). To main-
tain high quality of care, tailor-made algorithms should identify
speciﬁc high-risk patient populations who deserve in-depthFIG. 2. Flowchart of a clinical algorithm for the laboratory diagnosis of paras
laboratory can decide (a) to perform routine diagnostic care, i.e. PCR screenin
to consider based on patient characteristics and laboratory capacity, and/or (b)
or additional PCRs and serology for rare parasitic infections. For this purpose
expertise. (*) Decisive information could be: travel to, or originating from, hi
noticed by the patient (based on publication [17]).
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectdiagnostic analysis and allow for the identiﬁcation of rare
parasitic diseases. For these patient populations, ﬂexible and
highly specialized diagnostic parasitological tools are still
essential and should be maintained in designated referral
centres.itic infections in faeces. Based on the provided clinical information, the
g of the most relevant parasites, with additional PCR and serology tests
to perform in-depth parasitological research, including microscopy and/
the clinical sample could be referred to a regional or national centre of
gh-risk areas, eosinophilia, elevated IgE, urticaria, proglottids or worms
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 520–528
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